The treatment bill is only one part of mental illness’s cost. Dutch evidence places much of the economic burden in reduced work and daily functioning. A separate patient panel shows another important distinction: people can value professional care while still reporting poor quality of life. For families choosing private treatment, obtaining care and achieving the desired outcome are different questions.
Key findings
€18.8 billion: estimated additional annual costs associated with selected mental-health conditions among Dutch adults aged 18 to 75 in 2022.
€5,630: average additional cost per affected person, including healthcare, travel, and lost productivity or daily functioning.
61% to 85%: the share attributed to productivity losses, depending on the condition. These are modeled costs, not household invoices. [1]
6.3 versus 7.6: the life rating in a separate panel of people with long-term mental-health conditions compared with a general-population reference. About three quarters were satisfied with professional care. [2]
The largest cost can sit outside the treatment room
These are incremental cost estimates, not the price of a treatment program. People can belong to more than one condition group. Source: Trimbos, November 4, 2025. [1]
The findings support looking beyond appointment attendance. A lower healthcare bill can coexist with continuing problems at work or home. Extra care may also have value without immediately reducing spending.
The analysis does not identify how much of the economic burden could be prevented by a particular intervention. That would require a treatment comparison, not simply a national cost estimate.
A national average is not an executive budget
The €5,630 estimate should not be multiplied by a senior salary to produce an executive mental-health cost. Such a calculation would need evidence about the relevant population, actual work effects, and valuation method.
Income is not the value of every hour affected by symptoms. Family participation, rest, and ordinary activities matter without needing an inflated financial label.
For private-care decisions, ask which benefit the person hopes to achieve and how it will be assessed. A national burden estimate neither sets the appropriate treatment price nor proves that a more expensive program saves more money.
Satisfaction and quality of life tell different stories
| Indicator | Reported finding |
|---|---|
| Panel participants | 654 people with long-term mental-health conditions |
| Average life rating | 6.3, compared with 7.6 in the population reference |
| Satisfied with professional care | Approximately three quarters |
| One or more chronic physical conditions | 60% |
| Paid employment | 21% |
The panel was reported January 15, 2026. It is not a matched effectiveness trial or a representative sample of affluent households. The indicators overlap. [2]
Almost a quarter reported insufficient professional support. A person can appreciate a clinician’s effort and still need more help. That is not a contradiction, and neither finding should be dismissed.
It also does not prove care caused or failed to reduce the difficulties. Baseline needs and an appropriate comparison are necessary for that conclusion. The immediate reporting lesson is to keep experience, symptoms, and quality of life separate.
First-onset estimates need their own denominator
NEMESIS follow-up research found that around 11% of adults without a previous studied mental-health condition developed one over almost three years. Follow-up included 4,688 participants from an initial 6,194. Researchers translated the findings into approximately 275,000 first cases annually nationwide. That is an annualized survey estimate, not a diagnostic register count. [3]
Initial interviews ran from November 2019 to March 2022, with follow-up between January 2023 and November 2024. Publication in 2025 does not make these 2025 incidence observations.
For comparison with the earlier NEMESIS study, researchers used ages 18 to 64. The roughly three-year first-onset proportion rose from 9% to 14%. Those figures should not be mixed with the broader 18-to-75 estimate as though all share one denominator.
For a family-business discussion, the finding is not a prediction that a successor will become unwell. It supports keeping appropriate assessment and support available through changing life circumstances.
A reporting change is not proof that waiting improved
From January 2026, the Dutch Healthcare Authority began deriving waiting-time information for single-location mental-health providers from claims data rather than their previous manual submissions. Multiple-location providers remain under a transitional arrangement, with broader implementation planned for 2027. [4]
The intended improvement is in measurement and reporting burden. It does not establish that waiting times suddenly disappeared or fell.
Before comparing releases, check whether a figure concerns people still waiting, people who eventually started, or an expected wait reported by a provider. Those are different questions for someone deciding how to obtain care.
For affluent families, the uncertainty is which pathway fits
Being able to pay may widen the available options without clarifying which professional to approach or how several recommendations fit together. The national studies do not measure that experience specifically in HNW households.
A useful proposal explains who assesses the person, which needs take priority, and what happens when the first plan does not help enough. Convenience should not substitute for clinical fit.
Several providers also do not automatically make one coordinated plan. Ask who reconciles recommendations and communicates changes. Administrative availability and qualified clinical oversight are different responsibilities.
Work is one outcome, not the only one
A patient may prioritize sleep, independence, relationships, or a more sustainable distribution of responsibilities. Employment can be part of the plan without becoming its only legitimate goal.
A founder who chooses a different role may have made a considered decision. Someone who resumes the same role may still struggle. Neither outcome is fully described by a payroll record.
The questions should be specific: which responsibilities can be sustained, what support is wanted, and when should the plan be reviewed? A prestigious title is not proof of either wellness or vulnerability.
What a better private-care comparison would show
| Domain | Question | Evidence |
|---|---|---|
| Access | How quickly does appropriate care begin? | Defined start point and eligible population |
| Clinical change | Which needs improve? | Suitable measures, baseline values, and follow-up |
| Functioning | What can the person sustain? | Patient-relevant daily-life outcomes |
| Experience | Was care understandable and respectful? | Experience measured separately from effectiveness |
| Continuity | Who follows the person afterward? | Accepted handover and actual follow-up coverage |
This is a proposed framework, not a ranking of Dutch and foreign providers. THE BALANCE should face the same questions when presenting its own results.
For international care, receiving arrangements should be agreed rather than left as a list of suggestions. The patient should know who remains responsible when the location changes.
What the numbers cannot tell us
The sources do not establish private-care superiority, the cost of distress in a particular family business, or a recovery rate for wealthy people. The economic analysis and patient panel describe different populations and measures. Linking their themes does not make them one dataset.
The bottom line
Measure the life beyond the appointment. Dutch evidence shows why service use and satisfaction can leave important outcomes unanswered. Families should ask what changed, what did not, and who will support the next stage, not simply how many contacts were purchased.
For journalists
Key contrast: modeled costs extend beyond healthcare, while a separate patient panel reports positive care experiences alongside lower quality of life.
Important caveat: these are distinct studies, not a causal evaluation of private treatment.
Suggested attribution: THE BALANCE analysis of published Dutch mental-health evidence.
Methodology and sources
This narrative analysis separates modeled costs, panel experiences, incidence estimates, and reporting-system changes. Source periods and populations remain explicit. No new survey or provider-effect estimate was produced.


